Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Chronic Pain × Anastrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasms 7 Breast Neoplasms, Male 4 Neoplasm Metastasis 3 Carcinoma, Intraductal, Noninfiltrating 3 Arthralgia 3 Triple Negative Breast Neoplasms 2 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Pain 1 Osteoporosis 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Granulosa Cell Ovarian Cancer 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Carcinoma, Non-Small-Cell Lung 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Metastatic Breast Cancer 1 Advanced Breast Carcinoma 1

Interventions

morphine, naltrexone combination 1 Tapentadol 1 Nerve Block 1 Naltrexone 1 Morphine 1 Fentanyl 1 Anesthetics, Local 1 Anesthesia, Local 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡